Octreotide in the Medical Management of Chyle Fistula

Crumley RL Smith JD Postoperative chylous fistula prevention and management. Laryngoscope 1976;86:804–13.

Nussenbaum B Liu JH Sinard RJ Systematic management of chyle fistula: the Southwestern experience and review of the literature. Otolaryngol Head Neck Surg 2000;122:31–8.

Davis SN Granner DK Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Gilman AG Hardman JG Limbird LE , et al, editors. Goodman and Oilman's the pharmacological bbasis of therapeutics, 9th ed. New York: Pergamon Press; 1996. pp 1512–3.

Nakabayashi H Sagara H Usukura N , et al. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomized dogs. Diabetes 1981;30:440–5.

Ulibarri JI Sanz Y Fuentes C , et al. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 1990;336:258.

Kelly RF Shumway SJ Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg 2000;69:1944–5.